文献速递神经外周血管MR

既往COVID-19患者脑血管反应性与血管壁成像的前瞻性病例对照MRI研究

Evaluation of Cerebrovascular Reactivity and Vessel Wall Imaging in Patients With Prior COVID-19: A Prospective Case-Control MRI Study.
PubMed 文献 · AJR Am J Roentgenol · 2022-08-24

前瞻性病例对照研究纳入15例既往SARS-CoV-2感染者与10例从未感染者,采用乙酰唑胺负荷动脉自旋标记灌注MRI测量脑血流量并计算脑血管反应性(CVR),同时行增强黑血3D T1加权血管壁成像(VWI)。既往感染者全脑CVR显著低于对照(差值-8.9 mL/100 g/min,p<.001),VWI异常比例40%对10%(p=.18),差异无统计学意义,结论为SARS-CoV-2感染与CVR慢性受损相关。

要点

  • 既往感染者全脑CVR较未感染者低8.9 mL/100 g/min,提示感染后脑血管内皮功能可能持续受损。
  • 乙酰唑胺负荷后全皮质CBF既往感染者低于对照(60.5对73.8 mL/100 gm/min,p=.04)。
  • VWI异常均为动脉粥样硬化表现,两组比例差异无统计学意义,阅片时不应将其归因于新冠相关血管炎。

核心结论

  • SARS-CoV-2感染与脑血管反应性的慢性受损相关,但其机制本研究尚不明确。

研究设计与样本

  • 前瞻性病例对照研究,2021年7月1日至2022年2月9日纳入15例既往SARS-CoV-2感染者(11女4男,平均年龄43岁,距感染平均238天,3例既往重症、12例轻症、7例有新冠后神经系统症状)与10例从未感染者(2女2男,平均年龄44岁)。
  • 研究MRI包含乙酰唑胺刺激下的动脉自旋标记灌注成像,用于测量脑血流量并计算CVR;同时行增强黑血3D T1加权序列血管壁成像。
  • 采用年龄与性别校正的线性模型评估CVR与既往感染的关联,t检验评估既往感染者中CVR与新冠后神经系统症状的关联,比例差异检验评估VWI异常与感染状态的关联。

关键影像表现/征象

  • 既往感染者乙酰唑胺给药后全皮质平均CBF低于未感染者(60.5 ± 15.8 对 73.8 ± 13.2 mL/100 gm/min;p = .04)。
  • 既往感染者全脑CVR低于未感染者(差值-8.9 mL/100 g/min;p < .001),排除既往重症者后该差异仍显著。
  • VWI异常表现为动脉粥样硬化,既往感染者6/15(40%)至少一处VWI异常,未感染者1/10(10%),差异无统计学意义(p = .18)。

诊断标准与关键数值

  • CVR以乙酰唑胺刺激前后CBF变化计算,采用年龄与性别校正线性模型比较,全脑CVR组间差值为-8.9 mL/100 g/min(p < .001)。
  • VWI异常定义为增强黑血3D T1加权序列上至少一处异常,既往感染组6/15(40%)对未感染组1/10(10%),p = .18。
  • 既往感染者中,有与无新冠后神经系统症状者CVR分别为16.9对21.0 mL/100 g/min,差异无统计学意义(p = .22)。

临床应用与阅片要点

  • 阅片及科研测量CVR时可采用乙酰唑胺负荷ASL灌注,并注意年龄、性别校正对组间比较的影响。
  • 报告VWI异常时应描述为动脉粥样硬化性改变,避免直接归因于新冠相关内皮炎。
  • 对既往感染者出现神经系统症状时,可关注CVR受损这一潜在功能学改变,但目前尚无临床处理定论。

局限性

  • 样本量小(既往感染组15例、对照组10例),VWI异常组间比较未达统计学意义。
  • 单中心前瞻性研究,距感染时间平均238天,无法确定CVR受损的时间演变与可逆性。
  • CVR受损机制无法从本研究确定,且CVR降低与新冠后神经系统症状的关联未达统计学意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. SARS-CoV-2 infection is associated with acute stroke, possibly caused by viral tropism to the vascular endothelium. Whether cerebrovascular endothelial dysfunction and inflammation persist after acute infection is poorly understood. OBJECTIVE. The purposes of this study were to assess the association between prior SARS-CoV-2 infection and cerebrovascular reactivity (CVR) and vessel wall imaging (VWI) abnormalities and to explore the association between CVR impairment and post-COVID neurologic conditions. METHODS. This prospective study included 15 participants with prior SARS-CoV-2 infection (11 women, four men; mean age, 43 years; mean time since infection, 238 days; three with prior critical illness, 12 with prior mild illness; seven with post-COVID neurologic conditions) and 10 control participants who had never had SARS-CoV-2 infection (two women, two men; mean age, 44 years) from July 1, 2021, to February 9, 2022. Participants underwent research MRI that included arterial spin labeling perfusion imaging with acetazolamide stimulus to measure cerebral blood flow (CBF) and calculate CVR. Examinations also included VWI, performed with a contrast-enhanced black-blood 3D T1-weighted sequence. An age- and sex-adjusted linear model was used to assess associations between CVR and prior infection. A t test was used to assess associations between CVR and post-COVID neurologic conditions in participants with previous infection. A difference of proportions test was used to assess associations between VWI abnormalities and infection status. RESULTS. Mean whole-cortex CBF after acetazolamide administration was greater in participants without previous infection than in participants with previous infection (73.8 ± 13.2 [SD] vs 60.5 ± 15.8 mL/100 gm/min; p = .04). Whole-brain CVR was lower in participants with previous infection than those without previous infection (difference, -8.9 mL/100 g/min; p < .001); significantly lower CVR was also observed in participants with previous infection after exclusion of those with prior critical illness. Among participants with previous infection, CVR was lower in those with than those without post-COVID neurologic conditions, although this difference was not significant (16.9 vs 21.0 mL/100 g/min; p = .22). Six of 15 (40%) participants with previous infection versus 1 of 10 (10%) participants without previous infection had at least one VWI abnormality (p = .18). All VWI abnormalities were consistent with atherosclerosis. CONCLUSION. SARS-CoV-2 infection is associated with chronic impairment of CVR. The mechanism is unknown from this study. CLINICAL IMPACT. Future studies are needed to determine the clinical implications of SARS-CoV-2-associated CVR impairment.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Callen, Tanabe, Thaker, et al. Evaluation of Cerebrovascular Reactivity and Vessel Wall Imaging in Patients With Prior COVID-19: A Prospective Case-Control MRI Study. AJR Am J Roentgenol. 2022. PMID: 36000667. doi:10.2214/AJR.22.28267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。